Le Lézard
Classified in: Health, Business
Subject: LAW

Attorney Andy Birchfield Reacts to Proposed J&J Bankruptcy, Settlement Offer in Talc Litigation


MONTGOMERY, Ala., May 2, 2024 /PRNewswire/ -- Johnson & Johnson has proposed a $6.48 billion settlement in the talc-ovarian cancer litigation, hoping to reach consensus for the deal with the tens of thousands of women and families who have filed claims. If 75% of the claimants agree to the proposal, the company could "pre-package" the lawsuits through a third bankruptcy filing of a subsidiary company.

The following is a statement in reaction to this effort by Andy Birchfield, head of the Mass Torts section of the Beasley Allen Law Firm in Montgomery, Alabama:

"J&J has twice tried and failed to subvert our bankruptcy system. This is just the latest effort of a company with hundreds of billions in assets desperately trying to avoid legal and financial responsibility for decades of denial and deceit about the safety of its products. 

And with this latest scheme they are once again targeting their customers ? not a group of faceless creditors but real people, real families whose lives have been devastated simply because Johnson & Johnson abused their trust. 

But the company has once again miscalculated. These people, and the law firms that are proud to represent them, will continue to fight. This cynical attempt by J&J to break our collective resolve, bully these victims and abuse our courts will not succeed."   

Media Contact
Mark Annick
800-559-4534
[email protected]

SOURCE Beasley Allen Law Firm


These press releases may also interest you

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...



News published on and distributed by: